Avid Technology (AVID) 10-Q 9 Aug 23 2023 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2023	Aug. 04, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	1-36254
Entity Registrant Name	Avid Technology, Inc.
State of Incorporation	DE
Entity Tax Identification Number	04-2977748
Entity Address, Address Line One	75 Blue Sky Drive
Entity Address, City or Town	Burlington
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01803
City Area Code	978
Local Phone Number	640-6789
Title of Security	Common Stock, $0.01 par value
Trading Symbol	AVID
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		44,037,720
Entity Central Index Key	0000896841
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Net revenues:
Revenues	$ 108,542	$ 97,680	$ 206,353	$ 198,329
Cost of revenues:
Total cost of revenues	42,197	34,314	77,815	68,199
Gross profit	66,345	63,366	128,538	130,130
Operating expenses:
Research and development	20,000	16,023	39,426	32,759
Marketing and selling	25,391	23,673	48,048	45,600
General and administrative	16,020	13,364	32,634	28,175
Restructuring costs, net	5,462	342	5,462	357
Total operating expenses	66,873	53,402	125,570	106,891
Operating income (loss)	(528)	9,964	2,968	23,239
Interest expense, net	(4,214)	(1,944)	(7,929)	(3,420)
Other income (expense), net	20	79	167	(8)
(Loss) income before income taxes	(4,722)	8,099	(4,794)	19,811
(Benefit from) Provision for income taxes	(126)	726	183	1,852
Net (loss) income	$ (4,596)	$ 7,373	$ (4,977)	$ 17,959
Net (loss) income per common share – basic	$ (0.10)	$ 0.16	$ (0.11)	$ 0.40
Net (loss) income per common share – diluted	$ (0.10)	$ 0.16	$ (0.11)	$ 0.40
Weighted-average common shares outstanding – basic	44,099	44,740	43,957	44,778
Weighted-average common shares outstanding – diluted	44,099	45,110	43,957	45,280
Subscription
Net revenues:
Revenues	$ 44,439	$ 34,142	$ 83,824	$ 67,096
Cost of revenues:
Total cost of revenues	5,522	6,292	9,786	11,894
Maintenance
Net revenues:
Revenues			23,468	27,775
Cost of revenues:
Total cost of revenues	5,064	5,253
Integrated solutions & other
Net revenues:
Revenues	40,635	35,763	76,411	75,131
Cost of revenues:
Total cost of revenues	$ 31,611	$ 22,769	$ 58,218	$ 45,775

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Net (loss) income	$ (4,596)	$ 7,373	$ (4,977)	$ 17,959
Other comprehensive income (loss):
Foreign currency translation adjustments	(365)	(1,735)	229	(1,936)
Comprehensive income (loss)	$ (4,961)	$ 5,638	$ (4,748)	$ 16,023

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 33,502	$ 35,247
Restricted cash	926	2,413
Accounts receivable, net of allowances	58,679	76,849
Inventories	28,028	20,981
Prepaid expenses	10,696	8,360
Contract assets	38,487	32,295
Other current assets	3,360	2,826
Total current assets	173,678	178,971
Property and equipment, net	29,613	23,684
Goodwill	32,643	32,643
Right of use assets	20,756	21,395
Deferred tax assets, net	16,352	15,859
Other long-term assets	20,775	14,901
Total assets	293,817	287,453
Current liabilities:
Accounts payable	51,790	45,904
Accrued compensation and benefits	20,140	22,602
Accrued expenses and other current liabilities	39,165	36,031
Income taxes payable	142	62
Less: current portion	10,912	9,710
Deferred revenues	42,114	76,308
Total current liabilities	164,263	190,617
Long-term debt	202,213	172,958
Long-term deferred revenues	22,367	17,842
Long-term lease liabilities	19,884	20,470
Other long-term liabilities	4,044	4,348
Total liabilities	412,771	406,235
Commitments and contingencies (Note 7)
Stockholders' deficit:
Common stock, par value $0.01; authorized: 100,000 shares; issued: 46,935 shares at June 30, 2023 and 46,551 shares at December 31, 2022; outstanding: 44,009 shares at June 30, 2023 and 43,771 shares at December 31, 2022	465	462
Treasury stock	(78,353)	(77,933)
Additional paid-in capital	1,041,280	1,036,287
Accumulated deficit	(1,076,695)	(1,071,718)
Accumulated other comprehensive loss	(5,651)	(5,880)
Total stockholders' deficit	(118,954)	(118,782)
Total liabilities and stockholders' deficit	$ 293,817	$ 287,453

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Allowance for doubtful accounts	$ 539	$ 601
Stockholders' deficit:
Commons stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	46,935,000	46,551,000
Common stock, shares outstanding	44,009,000	43,771,000

CONSOLDATED STATEMENTS OF STOCK

CONSOLDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock, Common
Balances at beginning of period (in shares) at Dec. 31, 2021		45,828,000				(874,000)
Balances at beginning of period at Dec. 31, 2021	$ (124,074)	$ 455	$ 1,031,633	$ (1,126,959)	$ (4,113)	$ (25,090)
Stock issued pursuant to employee stock plans (in shares)		391,000
Stock issued pursuant to employee stock plans, net of shares withheld for employee tax obligations	(8,936)	$ 4	(8,940)
Stock Repurchased During Period, Shares						(354,000)
Repurchase of common stock	10,816					$ (10,816)
Stock-based compensation	3,422		3,422
Net loss	10,586			10,586
Other comprehensive income (loss)	(201)				(201)
Balances at end of period (in shares) at Mar. 31, 2022		46,219,000				(1,228,000)
Balances at end of period at Mar. 31, 2022	(130,019)	$ 459	1,026,115	(1,116,373)	(4,314)	$ (35,906)
Balances at beginning of period (in shares) at Dec. 31, 2021		45,828,000				(874,000)
Balances at beginning of period at Dec. 31, 2021	(124,074)	$ 455	1,031,633	(1,126,959)	(4,113)	$ (25,090)
Net loss	17,959
Balances at end of period (in shares) at Jun. 30, 2022		46,408,000				(1,788,000)
Balances at end of period at Jun. 30, 2022	(136,360)	$ 461	1,028,277	(1,109,000)	(6,049)	$ (50,049)
Balances at beginning of period (in shares) at Mar. 31, 2022		46,219,000				(1,228,000)
Balances at beginning of period at Mar. 31, 2022	(130,019)	$ 459	1,026,115	(1,116,373)	(4,314)	$ (35,906)
Stock issued pursuant to employee stock plans (in shares)		189,000
Stock issued pursuant to employee stock plans, net of shares withheld for employee tax obligations	(1,481)	$ 2	(1,483)
Stock Repurchased During Period, Shares						(560,000)
Repurchase of common stock	14,143					$ (14,143)
Stock-based compensation	3,645		3,645
Net loss	7,373			7,373
Other comprehensive income (loss)	(1,735)				(1,735)
Balances at end of period (in shares) at Jun. 30, 2022		46,408,000				(1,788,000)
Balances at end of period at Jun. 30, 2022	$ (136,360)	$ 461	1,028,277	(1,109,000)	(6,049)	$ (50,049)
Balances at beginning of period (in shares) at Dec. 31, 2022	43,771,000	46,551,000				(2,911,000)
Balances at beginning of period at Dec. 31, 2022	$ (118,782)	$ 462	1,036,287	(1,071,718)	(5,880)	$ (77,933)
Stock issued pursuant to employee stock plans (in shares)		212,000
Stock issued pursuant to employee stock plans, net of shares withheld for employee tax obligations	(4,840)	$ 2	(4,842)
Stock Repurchased During Period, Shares						(15,000)
Repurchase of common stock	420					$ (420)
Stock-based compensation	5,093		5,093
Net loss	(381)			(381)
Other comprehensive income (loss)	594				594
Balances at end of period (in shares) at Mar. 31, 2023		46,763,000				(2,926,000)
Balances at end of period at Mar. 31, 2023	$ (118,736)	$ 464	1,036,538	(1,072,099)	(5,286)	$ (78,353)
Balances at beginning of period (in shares) at Dec. 31, 2022	43,771,000	46,551,000				(2,911,000)
Balances at beginning of period at Dec. 31, 2022	$ (118,782)	$ 462	1,036,287	(1,071,718)	(5,880)	$ (77,933)
Net loss	$ (4,977)
Balances at end of period (in shares) at Jun. 30, 2023	44,009,000	46,935,000				(2,926,000)
Balances at end of period at Jun. 30, 2023	$ (118,954)	$ 465	1,041,280	(1,076,695)	(5,651)	$ (78,353)
Balances at beginning of period (in shares) at Mar. 31, 2023		46,763,000				(2,926,000)
Balances at beginning of period at Mar. 31, 2023	(118,736)	$ 464	1,036,538	(1,072,099)	(5,286)	$ (78,353)
Stock issued pursuant to employee stock plans (in shares)		172,000
Stock issued pursuant to employee stock plans, net of shares withheld for employee tax obligations	(1,199)	$ 1	(1,200)
Stock-based compensation	5,942		5,942
Net loss	(4,596)			(4,596)
Other comprehensive income (loss)	$ (365)				(365)
Balances at end of period (in shares) at Jun. 30, 2023	44,009,000	46,935,000				(2,926,000)
Balances at end of period at Jun. 30, 2023	$ (118,954)	$ 465	$ 1,041,280	$ (1,076,695)	$ (5,651)	$ (78,353)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ (4,977)	$ 17,959
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:
Depreciation and amortization	4,852	3,869
(Recovery from) allowance for doubtful accounts	(30)	222
Stock-based compensation expense	11,035	7,067
Non-cash provision for restructuring	5,462	338
Non-cash interest expense	298	247
Loss on disposal of fixed assets	0	548
Unrealized foreign currency transaction losses (gains)	874	(1,729)
Provision for (benefit from) deferred taxes	(498)	1,610
Changes in operating assets and liabilities:
Accounts receivable	18,200	22,945
Inventories	(7,047)	672
Prepaid expenses and other assets	(6,525)	(5,664)
Accounts payable	5,886	6,044
Accrued expenses, compensation and benefits and other liabilities	(5,559)	(16,105)
Income taxes payable	80	(776)
Deferred revenue and contract assets	(38,228)	(22,026)
Net cash (used in) provided by operating activities	(16,177)	15,221
Cash flows from investing activities:
Purchases of property and equipment	(10,008)	(7,359)
Net cash used in investing activities	(10,008)	(7,359)
Proceeds from revolving line of credit	35,000	19,000
Cash flows from financing activities:
Repayment of debt principal	(4,841)	(2,288)
Payments for repurchase of common stock	(572)	(25,262)
Common stock repurchases for tax withholdings for net settlement of equity awards	(6,525)	(10,885)
Payments for credit facility issuance costs	0	(440)
Net cash (used in) provided by financing activities	23,548	(19,407)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(645)	(941)
Net decrease in cash, cash equivalents and restricted cash	(3,282)	(12,486)
Cash, cash equivalents and restricted cash at beginning of period	38,852	60,556
Cash, cash equivalents and restricted cash at end of period	35,570	48,070
Supplemental information:
Cash and cash equivalents	33,502	44,332
Restricted cash	926	2,413
Restricted cash included in other long-term assets	1,142	1,325
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	35,570	48,070
Cash paid for income taxes	847	1,293
Cash paid for interest	6,809	1,542
Proceeds from the issuance of common stock under employee stock plans	$ 486	$ 468

FINANCIAL INFORMATION (Notes)

FINANCIAL INFORMATION (Notes)	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
FINANCIAL INFORMATION	FINANCIAL INFORMATION The accompanying condensed consolidated financial statements include the accounts of Avid Technology, Inc. and its wholly owned subsidiaries (collectively, “we” or “our”). These financial statements are unaudited. However, in the opinion of management, the condensed consolidated financial statements reflect all normal and recurring adjustments necessary for their fair statement. Interim results are not necessarily indicative of results expected for any other interim period or a full year. We prepared the accompanying unaudited condensed consolidated financial statements in accordance with the instructions for Form 10-Q and, therefore, include all information and footnotes necessary for a complete presentation of operations, comprehensive income, financial position, changes in stockholders’ deficit, and cash flows in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying condensed consolidated balance sheet as of December 31, 2022 was derived from our audited consolidated financial statements and does not include all disclosures required by U.S. GAAP for annual financial statements. We filed audited consolidated financial statements as of and for the year ended December 31, 2022 in our Annual Report on Form 10-K for the year ended December 31, 2022, which included information and footnotes necessary for such presentation. The financial statements contained in this Form 10-Q should be read in conjunction with the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2022. The consolidated results of operations for the three months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The Company’s results of operations are affected by economic conditions, including macroeconomic conditions and levels of business and consumer confidence. Our preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reported periods. Actual results could differ from our estimates. Significant Accounting Policies There have been no material changes to our significant accounting policies as compared to the significant accounting policies described in our Annual Report on Form 10-K for the year ended December 31, 2022.

NET INCOME PER SHARE Earnings P

NET INCOME PER SHARE Earnings Per Share (Notes)	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
NET INCOME PER SHARE	NET (LOSS) INCOME PER SHARE Net income per common share is presented for both basic income per share (“Basic EPS”) and diluted income per share (“Diluted EPS”). Basic EPS is based on the weighted-average number of common shares outstanding during the period. Diluted EPS is based on the weighted-average number of common shares and common share equivalents outstanding during the period. The potential common shares that were considered anti-dilutive securities were excluded from the diluted earnings per share calculations for the relevant periods either because the sum of the exercise price per share and the unrecognized compensation cost per share was greater than the average market price of our common stock for the relevant periods, or because they were considered contingently issuable. The contingently issuable potential common shares result from certain restricted stock units granted to our employees that vest based on performance conditions, market conditions, or a combination of performance and market conditions. The following table sets forth (in thousands) potential common shares that were considered anti-dilutive securities at June 30, 2023 and 2022: June 30, 2023 June 30, 2022 Non-vested restricted stock units 1,291 826 The following table sets forth (in thousands) the basic and diluted weighted common shares outstanding for the three months ended June 30, 2023 and 2022: Three months ended Six months ended June 30, 2023 June 30, 2022 June 30, 2023 June 30, 2022 Weighted common shares outstanding - basic 44,099 44,740 43,957 44,778 Net effect of common stock equivalents — 370 — 502 Weighted common shares outstanding - diluted 44,099 45,110 43,957 45,280

FAIR VALUE MEASUREMENTS (Notes)

FAIR VALUE MEASUREMENTS (Notes)	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS Assets Measured at Fair Value on a Recurring Basis We measure deferred compensation investments on a recurring basis. As of June 30, 2023 and December 31, 2022, our deferred compensation investments were classified as either Level 1 or Level 2 in the fair value hierarchy. Assets valued using quoted market prices in active markets and classified as Level 1 are money market and mutual funds. Assets valued based on other observable inputs and classified as Level 2 are insurance contracts. The assets held at fair value are included in “Other current assets” and “Other long-term assets” on our consolidated balance sheet as of June 30, 2023 and 2022. The following tables summarize our deferred compensation investments measured at fair value on a recurring basis (in thousands): Fair Value Measurements at Reporting Date Using June 30, Quoted Prices in Significant Significant Financial assets: Deferred compensation assets $ 281 $ 87 $ 194 $ — Fair Value Measurements at Reporting Date Using December 31, 2022 Quoted Prices in Significant Significant Financial assets: Deferred compensation assets $ 376 $ 85 $ 291 $ — Financial Instruments Not Recorded at Fair Value The carrying amounts of our other financial assets and liabilities including cash, accounts receivable, accounts payable, and accrued liabilities approximate their respective fair values because of the relatively short period of time between their origination and their expected realization or settlement. The carrying value of the term loan is net of debt issuance costs and approximates its fair value. Cash and equivalents were classified as Level 1 and all other financial instruments were classified as Level 2 within the fair value hierarchy.

INVENTORIES (Notes)

INVENTORIES (Notes)	6 Months Ended
	Jun. 30, 2023
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Inventories consisted of the following (in thousands): June 30, 2023 December 31, 2022 Raw materials $ 6,964 $ 7,984 Work in process 288 288 Finished goods 20,776 12,709 Total $ 28,028 $ 20,981

LEASES LEASES (Notes)

LEASES LEASES (Notes)	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
LEASES	LEASES We have entered into a number of facility leases to support our research and development activities, sales operations, and other corporate and administrative functions in North America, Europe, and Asia, which qualify as operating leases under U.S. GAAP. We also have a limited number of equipment leases that qualify as either operating or finance leases. We determine if contracts with vendors represent a lease or have a lease component under U.S. GAAP at contract inception. Our leases have remaining terms ranging from less than one year to five years. Some of our leases include options to extend or terminate the lease prior to the end of the agreed upon lease term. For purposes of calculating lease liabilities, lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise such options. Operating lease right of use assets and liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the lease commencement date. As our leases generally do not provide an implicit rate, we use an estimated incremental borrowing rate in determining the present value of future payments. The incremental borrowing rate represents an estimate of the interest rate we would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease within a particular location and currency environment. As of June 30, 2023, the weighted average incremental borrowing rate was 6.0% and the weighted average remaining lease term was 4.7 years. Finance lease right of use assets and liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the lease commencement date. Each lease agreement provides an implicit discount rate used to determine the present value of future payments. As of June 30, 2023, the weighted-average discount rate was 1.2% and the weighted average remaining lease term was less than one year. Lease costs for minimum lease payments is recognized on a straight-line basis over the lease term. Our total operating lease costs were $1.5 million and $1.4 million for the three months ended June 30, 2023 and June 30, 2022, respectively and $3.0 million and $2.9 million for the six months ended June 30, 2023 and June 30, 2022, respectively. Related cash payments were $1.5 million and $1.5 million for the three months ended June 30, 2023 and June 30, 2022, respectively, and $3.2 million and $3.1 million for the six months ended June 30, 2023 and June 30, 2022, respectively. Short term lease costs were $0.5 million and $0.6 million for the three months ended June 30, 2023 and June 30, 2022, respectively, and $1.1 million and $1.2 million for the six months ended June 30, 2023 and June 30, 2022, respectively. Operating lease costs are included within costs of revenue, research and development, marketing and selling, and general and administrative lines on the condensed consolidated statements of operations, and the related cash payments are included in the operating cash flows on the condensed consolidated statements of cash flows. Finance lease costs, variable lease costs, and sublease income are not material. The table below reconciles the undiscounted future minimum lease payments for operating and finance leases under non-cancelable leases with terms of more than one year to the total lease liabilities recognized on the condensed consolidated balance sheets as of June 30, 2023 (in thousands): Year Ending December 31, Operating Leases Finance Leases 2023 (excluding six months ended June 30, 2023) $ 3,125 $ 94 2024 5,840 41 2025 5,898 — 2026 5,958 — 2027 5,500 — Thereafter 2,067 — Total future minimum lease payments $ 28,388 $ 135 Less effects of discounting (3,822) — Total lease liabilities $ 24,566 $ 135 Supplemental balance sheet information related to leases was as follows (in thousands): Operating Leases June 30, 2023 Right of use assets $ 20,756 Accrued expenses and other current liabilities (4,682) Long-term lease liabilities (19,884) Total lease liabilities $ (24,566) Finance Leases June 30, 2023 Other assets $ 132 Accrued expenses and other current liabilities 135 Total lease liabilities $ 135
LEASES	LEASES We have entered into a number of facility leases to support our research and development activities, sales operations, and other corporate and administrative functions in North America, Europe, and Asia, which qualify as operating leases under U.S. GAAP. We also have a limited number of equipment leases that qualify as either operating or finance leases. We determine if contracts with vendors represent a lease or have a lease component under U.S. GAAP at contract inception. Our leases have remaining terms ranging from less than one year to five years. Some of our leases include options to extend or terminate the lease prior to the end of the agreed upon lease term. For purposes of calculating lease liabilities, lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise such options. Operating lease right of use assets and liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the lease commencement date. As our leases generally do not provide an implicit rate, we use an estimated incremental borrowing rate in determining the present value of future payments. The incremental borrowing rate represents an estimate of the interest rate we would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease within a particular location and currency environment. As of June 30, 2023, the weighted average incremental borrowing rate was 6.0% and the weighted average remaining lease term was 4.7 years. Finance lease right of use assets and liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the lease commencement date. Each lease agreement provides an implicit discount rate used to determine the present value of future payments. As of June 30, 2023, the weighted-average discount rate was 1.2% and the weighted average remaining lease term was less than one year. Lease costs for minimum lease payments is recognized on a straight-line basis over the lease term. Our total operating lease costs were $1.5 million and $1.4 million for the three months ended June 30, 2023 and June 30, 2022, respectively and $3.0 million and $2.9 million for the six months ended June 30, 2023 and June 30, 2022, respectively. Related cash payments were $1.5 million and $1.5 million for the three months ended June 30, 2023 and June 30, 2022, respectively, and $3.2 million and $3.1 million for the six months ended June 30, 2023 and June 30, 2022, respectively. Short term lease costs were $0.5 million and $0.6 million for the three months ended June 30, 2023 and June 30, 2022, respectively, and $1.1 million and $1.2 million for the six months ended June 30, 2023 and June 30, 2022, respectively. Operating lease costs are included within costs of revenue, research and development, marketing and selling, and general and administrative lines on the condensed consolidated statements of operations, and the related cash payments are included in the operating cash flows on the condensed consolidated statements of cash flows. Finance lease costs, variable lease costs, and sublease income are not material. The table below reconciles the undiscounted future minimum lease payments for operating and finance leases under non-cancelable leases with terms of more than one year to the total lease liabilities recognized on the condensed consolidated balance sheets as of June 30, 2023 (in thousands): Year Ending December 31, Operating Leases Finance Leases 2023 (excluding six months ended June 30, 2023) $ 3,125 $ 94 2024 5,840 41 2025 5,898 — 2026 5,958 — 2027 5,500 — Thereafter 2,067 — Total future minimum lease payments $ 28,388 $ 135 Less effects of discounting (3,822) — Total lease liabilities $ 24,566 $ 135 Supplemental balance sheet information related to leases was as follows (in thousands): Operating Leases June 30, 2023 Right of use assets $ 20,756 Accrued expenses and other current liabilities (4,682) Long-term lease liabilities (19,884) Total lease liabilities $ (24,566) Finance Leases June 30, 2023 Other assets $ 132 Accrued expenses and other current liabilities 135 Total lease liabilities $ 135

OTHER LONG-TERM LIABILITIES (No

OTHER LONG-TERM LIABILITIES (Notes)	6 Months Ended
	Jun. 30, 2023
Other Liabilities Disclosure [Abstract]
OTHER LONG-TERM LIABILITIES	OTHER LONG-TERM LIABILITIES Other long-term liabilities consisted of the following (in thousands): June 30, 2023 December 31, 2022 Deferred compensation $ 3,493 $ 3,715 Finance lease liabilities — 46 Other long-term liabilities 551 587 Total $ 4,044 $ 4,348

CONTINGENCIES (Notes)

CONTINGENCIES (Notes)	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Commitments We entered into a long-term agreement to purchase a variety of information technology solutions from a third party in the second quarter of 2020, which included an unconditional commitment to purchase a minimum of $32.2 million of products and services over the initial five years of the agreement. We have purchased $23.5 million of products and services pursuant to this agreement as of June 30, 2023. We have letters of credit that are used as security deposits in connection with our leased Burlington, Massachusetts office space. In the event of default on the underlying leases, the landlords would, at June 30, 2023, be eligible to draw against the letters of credit to a maximum of $0.7 million. We also have letters of credit in connection with security deposits for other facility leases totaling $0.4 million in the aggregate, as well as letters of credit totaling $3.4 million that otherwise support our ongoing operations. These letters of credit have various terms and expire during 2023 and beyond, while some of the letters of credit may automatically renew based on the terms of the underlying agreements. Letters of credit that are collateralized by restricted cash are included in the caption “Restricted cash” and “Other long-term assets” on our condensed consolidated balance sheets as of June 30, 2023. Contingencies Our industry is characterized by the existence of a large number of patents and frequent claims and litigation regarding patent and other intellectual property rights. In addition to the legal proceedings described below, we are involved in legal proceedings from time to time arising from the normal course of business activities, including claims of alleged infringement of intellectual property rights and contractual, commercial, employee relations, product or service performance, or other matters. We do not believe these matters will have a material adverse effect on our financial position or results of operations. However, the outcome of legal proceedings and claims brought against us is subject to significant uncertainty. Therefore, our financial position or results of operations may be negatively affected by the unfavorable resolution of one or more of these proceedings for the period in which a matter is resolved. Our results could be materially adversely affected if we are accused of, or found to be, infringing third parties’ intellectual property rights. Following the termination of our former Chairman and Chief Executive Officer on February 25, 2018, we received a notice alleging that we breached the former employee’s employment agreement. On April 16, 2019, we received an additional notice again alleging we breached the former employee’s employment agreement. We have since been in communications with our former Chairman and Chief Executive Officer’s counsel. While we intend to defend any claim vigorously, when and if a claim is actually filed, we are currently unable to estimate an amount or range of any reasonably possible losses that could occur as a result of this matter. On July 14, 2020, we sent a notice to a customer demanding sums that we believe are due to Avid pursuant to a contract. On October 7, 2020, the customer sent a notice to us denying any legal liability and demanding payment for breach of contract resulting from various alleged delays by us. While we intend to defend any claim vigorously when and if a claim is actually filed, we are currently unable to estimate an amount or range of any reasonably possible losses that could occur related to this matter. We consider all claims on a quarterly basis and based on known facts assess whether potential losses are considered reasonably possible, probable, and estimable. Based upon this assessment, we then evaluate disclosure requirements and whether to accrue for such claims in our condensed consolidated financial statements. We record a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated and such amount is material. These provisions are reviewed at least quarterly and adjusted to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. At June 30, 2023 and as of the date of filing of these condensed consolidated financial statements, we believe that, other than as set forth in this note, no provision for liability nor disclosure is required related to any claims because: (a) there is no reasonable possibility that a loss exceeding amounts already recognized (if any) may be incurred with respect to such claim, (b) a reasonably possible loss or range of loss cannot be estimated, or (c) such estimate is immaterial. Additionally, we provide indemnification to certain customers for losses incurred in connection with intellectual property infringement claims brought by third parties with respect to our products. These indemnification provisions generally offer perpetual coverage for infringement claims based upon the products covered by the agreement and the maximum potential amount of future payments we could be required to make under these indemnification provisions is theoretically unlimited. To date, we have not incurred material costs related to these indemnification provisions; accordingly, we believe the estimated fair value of these indemnification provisions is immaterial. Further, certain arrangements with customers include clauses whereby we may be subject to penalties for failure to meet certain performance obligations; however, we have not recorded any related material penalties to date. We provide warranties on externally sourced and internally developed hardware. For internally developed hardware, and in cases where the warranty granted to customers for externally sourced hardware is greater than that provided by the manufacturer, we record an accrual for the related liability based on historical trends and actual material and labor costs. The following table sets forth the activity in the product warranty accrual account for the six months ended June 30, 2023 and 2022 (in thousands): Six Months Ended June 30, 2023 2022 Accrual balance at beginning of period $ 941 $ 1,219 Accruals for product warranties 354 305 Costs of warranty claims (423) (551) Accrual balance at end of period $ 872 $ 973 The warranty accrual is included in the caption “accrued expenses and other current liabilities” in our condensed consolidated balance sheet.

REVENUE (Notes)

REVENUE (Notes)	6 Months Ended
	Jun. 30, 2023
Revenue from Contract with Customer [Abstract]
REVENUE	REVENUE Disaggregated Revenue and Geography Information Through the evaluation of the discrete financial information that is regularly reviewed by the chief operating decision makers (our chief executive officer and chief financial officer), we have determined that we have one reporting unit and operating segment. The following table sets forth our revenues by geographic region for the three and six months ended June 30, 2023 and 2022 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Revenues: United States $ 46,601 $ 40,160 $ 87,029 $ 84,549 Other Americas 5,097 8,406 15,298 13,300 Europe, Middle East and Africa 41,006 36,316 73,927 75,161 Asia-Pacific 15,838 12,798 30,099 25,319 Total net revenues $ 108,542 $ 97,680 $ 206,353 $ 198,329 Contract Asset Contract asset activity for the six months ended June 30, 2023 and 2022 was as follows (in thousands): June 30, 2023 June 30, 2022 Contract asset at beginning of period $ 37,765 $ 25,397 Revenue in excess of billings 47,651 19,735 Customer billings (39,092) (14,858) Contract asset at end of period $ 46,324 $ 30,274 Less: long-term portion (recorded in other long-term assets) 7,837 9,324 Contract asset, current portion $ 38,487 $ 20,950 Deferred Revenue Deferred revenue activity for the six months ended June 30, 2023 and 2022 was as follows (in thousands): June 30, 2023 June 30, 2022 Deferred revenue at beginning of period $ 94,150 $ 98,082 Billings deferred 40,831 45,192 Recognition of prior deferred revenue (70,500) (62,341) Deferred revenue at end of period $ 64,481 $ 80,933 A summary of the significant performance obligations included in deferred revenue is as follows (in thousands): June 30, 2023 Product $ 1,672 Subscription 14,926 Maintenance contracts 42,885 Implied PCS 3,233 Professional services, training and other 1,765 Deferred revenue at June 30, 2023 $ 64,481 Remaining Performance Obligations For transaction prices allocated to remaining performance obligations, we apply practical expedients and do not disclose quantitative or qualitative information for remaining performance obligations (i) that have original expected durations of one year or less and (ii) where we recognize revenue equal to what we have the right to invoice and that amount corresponds directly with the value to the customer of our performance to date. Historically, for many of our products, we had an ongoing practice of making when-and-if-available software updates available to customers free of charge for a period of time after initial sales to customers. The expectation created by this practice of providing free Software Updates represents an implied obligation of a form of post-contract customer support (“Implied PCS”) which represents a performance obligation. While we have ceased providing Implied PCS on new product offerings, we continue to provide Implied PCS for older products that were predominately sold in prior years. Revenue attributable to Implied PCS performance obligations is recognized over time on a ratable basis over the period that Implied PCS is expected to be provided, which is typically six years. We have remaining performance obligations of $3.2 million attributable to Implied PCS recorded in deferred revenue as of June 30, 2023. We expect to recognize revenue for these remaining performance obligations of $0.7 million for the remainder of 2023 and $1.1 million, $0.7 million, $0.4 million and $0.2 million for the years ending December 31, 2024, 2025, 2026, and 2027, respectively, and an immaterial amount thereafter. As of June 30, 2023, we had approximately $14.7 million of transaction price allocated to remaining performance obligations for certain enterprise agreements that have not yet been fully invoiced. Approximately $13.4 million of these performance obligations were unbilled as of June 30, 2023. Remaining performance obligations represent obligations we must deliver for specific products and services in the future where there is not yet an enforceable right to invoice the customer. Our remaining performance obligations do not include contractually committed minimum purchases that are common in our strategic purchase agreements with resellers since our specific obligations to deliver products or services is not yet known, as customers may satisfy such commitments by purchasing an unknown combination of current or future product offerings. While the timing of fulfilling individual performance obligations under the contracts can vary dramatically based on customer requirements, we expect to recognize the $14.7 million in roughly equal installments through 2028. Remaining performance obligation estimates are subject to change and are affected by several factors, including terminations due to contract breach, contract amendments, and changes in the expected timing of delivery.

LONG-TERM DEBT AND CREDIT AGREE

LONG-TERM DEBT AND CREDIT AGREEMENT (Notes)	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
LONG TERM DEBT AND CREDIT AGREEMENT	LONG-TERM DEBT AND CREDIT AGREEMENT Long-term debt consisted of the following (in thousands): June 30, 2023 December 31, 2022 Term Loan, net of unamortized issuance costs and debt discount of $2,187 and $2,485 at June 30, 2023 and December 31, 2022, respectively $ 177,375 $ 181,853 Credit Facility 35,000 — Other long-term debt 750 815 Total debt $ 213,125 $ 182,668 Less: current portion 10,912 9,710 Total long-term debt $ 202,213 $ 172,958 The following table summarizes the contractual maturities of our borrowing obligations as of June 30, 2023 (in thousands): Fiscal Year Term Loan Credit Facility Other Long-Term Debt Total 2023 (excluding six months ended June 30, 2023) $ 4,775 — 83 $ 4,858 2024 13,131 — 174 13,305 2025 17,906 — 187 18,093 2026 19,100 — 200 19,300 2027 124,650 35,000 106 159,756 Total before unamortized discount 179,562 35,000 750 215,312 Less: unamortized discount and issuance costs (2,187) — — (2,187) Less: current portion of long-term debt (10,744) — (168) (10,912) Total long-term debt $ 166,631 35,000 $ 582 $ 202,213 Credit Agreement On January 5, 2021, the Company entered into a Credit Agreement (the “Credit Agreement”) with JPMorgan Chase Bank, N.A. as collateral and administrative agent, and a syndicate of banks, as lenders thereunder (the “Lenders”). Pursuant to the Credit Agreement, the Lenders agreed to provide the Company with (a) a term loan in the aggregate principal amount of $180.0 million (the “Term Loan”) and (b) a revolving credit facility (the “Revolving Credit Facility”) of up to a maximum of $70.0 million in borrowings outstanding at any time. The Revolving Credit Facility can be used for working capital, other general corporate purposes and for other permitted uses. The proceeds from the Term Loan, plus available cash on hand, were used to repay outstanding borrowings in the principal amount of $201 million under the Company’s prior financing agreement, which was then terminated. In connection with this termination, the Company incurred a loss on extinguishment of debt of $3.7 million as a result of writing off $2.6 million of remaining unamortized issuance costs as well as a $1.1 million prepayment penalty. In connection with the Credit Agreement, the Company incurred $2.5 million of issuance discounts and an immaterial amount of issuance costs. The Term Loan discount and issuance costs are being amortized over the remaining life of the Second A&R Credit Agreement (as defined below). On February 25, 2022, the Company executed an Amended and Restated Credit Agreement (the “A&R Credit Agreement) with JPMorgan Chase Bank, N.A. and the Lenders. The A&R Credit Agreement extended the term of the Term Loan to February 25, 2027, reduced the applicable interest rate margins by 0.25%, removed the LIBOR floor, moved the reference rate from LIBOR to the Secured Overnight Financing Rate (“SOFR”), reset the principal amortization schedule, and eliminated the fixed charge coverage ratio. In connection with the A&R Credit Agreement, the Company accounted for the amendment as a modification and incurred an additional $0.4 million of issuance costs during the three months ended March 31, 2022. These additional costs and the remaining unamortized Term Loan discount and issuance costs are being amortized jointly over the amended remaining life of the Second A&R Credit Agreement. On October 6, 2022, the Company executed a Second Amended and Restated Credit Agreement (the “Second A&R Credit Agreement”) with JPMorgan Chase Bank, N.A. and the Lenders. Pursuant to the Second A&R Credit Agreement, the Lenders agreed to provide the Company with (a) an additional term loan in the aggregate principal amount of $20 million (of which approximately $19 million was used to pay off the Company’s then outstanding drawings under the Revolving Credit Facility), and (b) an additional $50 million of available borrowing capacity under the Revolving Credit Facility, increasing the aggregate amount available to $120.0 million. The Second A&R Credit Agreement includes substantially similar terms as the A&R Credit Agreement and does not result in any changes to financial covenants, pricing or the maturity date of February 25, 2027. In connection with the Second A&R Credit Agreement, the Company accounted for the amendment as a modification and incurred an additional $0.5 million of issuance costs during the three months ended December 31, 2022. These additional costs and the remaining unamortized Term Loan discount and issuance costs are being amortized jointly over the amended remaining life of the Second A&R Credit Agreement. We recorded $3.8 million and $7.1 million of interest expense on the Term Loan and Revolving Credit Facility for the three and six months ended June 30, 2023. The effective interest rate for the six months ended June 30, 2023 was 7.05%. As of June 30, 2023, there was $35 million outstanding under the Revolving Credit Facility. We were in compliance with the Second A&R Credit Agreement covenants as of June 30, 2023.

STOCKHOLDERS' EQUITY (Notes)

STOCKHOLDERS' EQUITY (Notes)	6 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
STOCKHOLDERS' EQUITY	STOCKHOLDERS’ EQUITY Stock-Based Compensation Information with respect to the Company’s non-vested time-based restricted stock units for the six months ended June 30, 2023 was as follows: Number of Restricted Stock Units Weighted- Weighted- Aggregate Shares Retained to Cover Statutory Minimum Withholding Taxes Non-vested at January 1, 2023 788,217 $28.24 — Granted 597,436 30.05 — Vested (332,078) 25.00 (109,740) Forfeited (42,805) 32.22 — Non-vested at June 30, 2023 1,010,770 $30.21 1.10 $32,314 Information with respect to the Company’s non-vested performance-based restricted stock units for the six months ended June 30, 2023 was as follows: Number of Performance-based Restricted Stock Units Weighted- Weighted- Aggregate Shares Retained to Cover Statutory Minimum Withholding Taxes Non-vested at January 1, 2023 294,011 $23.20 — Granted 240,598 26.12 — Vested (254,320) 15.34 (114,881) Forfeited — — — Non-vested at June 30, 2023 280,289 $32.85 1.43 $8,961 The following table sets forth stock-based compensation expense by award type for the three and six months ended June 30, 2023 and 2022 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Share-based compensation expense by type: Time-based Restricted Stock Units $ 4,748 $ 2,952 $ 8,913 $ 5,380 Performance-based Restricted Stock Units 1,140 643 2,022 1,591 ESPP 54 50 100 96 Total share-based compensation expense $ 5,942 $ 3,645 $ 11,035 $ 7,067 Stock-based compensation was included in the following captions in the Company’s condensed consolidated statements of operations for the three and six months ended June 30, 2023 and 2022 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Cost of revenues $ 984 $ 589 $ 1,413 $ 1,015 Research and development expenses 1,216 515 1,684 865 Marketing and selling expenses 1,036 800 1,845 1,398 General and administrative expenses 2,706 1,741 6,093 3,789 Total share-based compensation expense $ 5,942 $ 3,645 $ 11,035 $ 7,067

FINANCIAL INFORMATION (Policies

FINANCIAL INFORMATION (Policies)	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Revenue from Contract with Customer	Significant Accounting Policies There have been no material changes to our significant accounting policies as compared to the significant accounting policies described in our Annual Report on Form 10-K for the year ended December 31, 2022.
Recent Accounting Pronouncements

NET INCOME PER SHARE Earnings_2

NET INCOME PER SHARE Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Schedule of Antidilutive Securities Excluded From Computation of Net (Income) Loss Per Share	The following table sets forth (in thousands) potential common shares that were considered anti-dilutive securities at June 30, 2023 and 2022: June 30, 2023 June 30, 2022 Non-vested restricted stock units 1,291 826
Schedule of Weighted Average Number of Shares	The following table sets forth (in thousands) the basic and diluted weighted common shares outstanding for the three months ended June 30, 2023 and 2022: Three months ended Six months ended June 30, 2023 June 30, 2022 June 30, 2023 June 30, 2022 Weighted common shares outstanding - basic 44,099 44,740 43,957 44,778 Net effect of common stock equivalents — 370 — 502 Weighted common shares outstanding - diluted 44,099 45,110 43,957 45,280

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Financial assets and liabilities measured at fair value on a recurring basis	The following tables summarize our deferred compensation investments measured at fair value on a recurring basis (in thousands): Fair Value Measurements at Reporting Date Using June 30, Quoted Prices in Significant Significant Financial assets: Deferred compensation assets $ 281 $ 87 $ 194 $ — Fair Value Measurements at Reporting Date Using December 31, 2022 Quoted Prices in Significant Significant Financial assets: Deferred compensation assets $ 376 $ 85 $ 291 $ —

INVENTORIES (Tables)

INVENTORIES (Tables)	6 Months Ended
	Jun. 30, 2023
Inventory Disclosure [Abstract]
Inventories	Inventories consisted of the following (in thousands): June 30, 2023 December 31, 2022 Raw materials $ 6,964 $ 7,984 Work in process 288 288 Finished goods 20,776 12,709 Total $ 28,028 $ 20,981

LEASES LEASES (Tables)

LEASES LEASES (Tables)	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Lessee, Operating Lease, Liability, Maturity	The table below reconciles the undiscounted future minimum lease payments for operating and finance leases under non-cancelable leases with terms of more than one year to the total lease liabilities recognized on the condensed consolidated balance sheets as of June 30, 2023 (in thousands): Year Ending December 31, Operating Leases Finance Leases 2023 (excluding six months ended June 30, 2023) $ 3,125 $ 94 2024 5,840 41 2025 5,898 — 2026 5,958 — 2027 5,500 — Thereafter 2,067 — Total future minimum lease payments $ 28,388 $ 135 Less effects of discounting (3,822) — Total lease liabilities $ 24,566 $ 135
Finance Lease, Liability, Maturity	The table below reconciles the undiscounted future minimum lease payments for operating and finance leases under non-cancelable leases with terms of more than one year to the total lease liabilities recognized on the condensed consolidated balance sheets as of June 30, 2023 (in thousands): Year Ending December 31, Operating Leases Finance Leases 2023 (excluding six months ended June 30, 2023) $ 3,125 $ 94 2024 5,840 41 2025 5,898 — 2026 5,958 — 2027 5,500 — Thereafter 2,067 — Total future minimum lease payments $ 28,388 $ 135 Less effects of discounting (3,822) — Total lease liabilities $ 24,566 $ 135
Assets and Liabilities, Lessee	Supplemental balance sheet information related to leases was as follows (in thousands): Operating Leases June 30, 2023 Right of use assets $ 20,756 Accrued expenses and other current liabilities (4,682) Long-term lease liabilities (19,884) Total lease liabilities $ (24,566) Finance Leases June 30, 2023 Other assets $ 132 Accrued expenses and other current liabilities 135 Total lease liabilities $ 135

OTHER LONG-TERM LIABILITIES (Ta

OTHER LONG-TERM LIABILITIES (Tables)	6 Months Ended
	Jun. 30, 2023
Other Liabilities Disclosure [Abstract]
Long-term liabilities	Other long-term liabilities consisted of the following (in thousands): June 30, 2023 December 31, 2022 Deferred compensation $ 3,493 $ 3,715 Finance lease liabilities — 46 Other long-term liabilities 551 587 Total $ 4,044 $ 4,348

CONTINGENCIES (Tables)

CONTINGENCIES (Tables)	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Product warranty accrual activity	The following table sets forth the activity in the product warranty accrual account for the six months ended June 30, 2023 and 2022 (in thousands): Six Months Ended June 30, 2023 2022 Accrual balance at beginning of period $ 941 $ 1,219 Accruals for product warranties 354 305 Costs of warranty claims (423) (551) Accrual balance at end of period $ 872 $ 973

REVENUE (Tables)

REVENUE (Tables)	6 Months Ended
	Jun. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue by Type
Revenue by Geographic Region	The following table sets forth our revenues by geographic region for the three and six months ended June 30, 2023 and 2022 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Revenues: United States $ 46,601 $ 40,160 $ 87,029 $ 84,549 Other Americas 5,097 8,406 15,298 13,300 Europe, Middle East and Africa 41,006 36,316 73,927 75,161 Asia-Pacific 15,838 12,798 30,099 25,319 Total net revenues $ 108,542 $ 97,680 $ 206,353 $ 198,329
Contract Asset	Contract Asset Contract asset activity for the six months ended June 30, 2023 and 2022 was as follows (in thousands): June 30, 2023 June 30, 2022 Contract asset at beginning of period $ 37,765 $ 25,397 Revenue in excess of billings 47,651 19,735 Customer billings (39,092) (14,858) Contract asset at end of period $ 46,324 $ 30,274 Less: long-term portion (recorded in other long-term assets) 7,837 9,324 Contract asset, current portion $ 38,487 $ 20,950
Deferred Revenue	Deferred revenue activity for the six months ended June 30, 2023 and 2022 was as follows (in thousands): June 30, 2023 June 30, 2022 Deferred revenue at beginning of period $ 94,150 $ 98,082 Billings deferred 40,831 45,192 Recognition of prior deferred revenue (70,500) (62,341) Deferred revenue at end of period $ 64,481 $ 80,933 A summary of the significant performance obligations included in deferred revenue is as follows (in thousands): June 30, 2023 Product $ 1,672 Subscription 14,926 Maintenance contracts 42,885 Implied PCS 3,233 Professional services, training and other 1,765 Deferred revenue at June 30, 2023 $ 64,481

LONG-TERM DEBT AND CREDIT AGR_2

LONG-TERM DEBT AND CREDIT AGREEMENT (Tables)	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Schedule of Long-term Debt	Long-term debt consisted of the following (in thousands): June 30, 2023 December 31, 2022 Term Loan, net of unamortized issuance costs and debt discount of $2,187 and $2,485 at June 30, 2023 and December 31, 2022, respectively $ 177,375 $ 181,853 Credit Facility 35,000 — Other long-term debt 750 815 Total debt $ 213,125 $ 182,668 Less: current portion 10,912 9,710 Total long-term debt $ 202,213 $ 172,958
Schedule of Maturities of Long-term Debt	The following table summarizes the contractual maturities of our borrowing obligations as of June 30, 2023 (in thousands): Fiscal Year Term Loan Credit Facility Other Long-Term Debt Total 2023 (excluding six months ended June 30, 2023) $ 4,775 — 83 $ 4,858 2024 13,131 — 174 13,305 2025 17,906 — 187 18,093 2026 19,100 — 200 19,300 2027 124,650 35,000 106 159,756 Total before unamortized discount 179,562 35,000 750 215,312 Less: unamortized discount and issuance costs (2,187) — — (2,187) Less: current portion of long-term debt (10,744) — (168) (10,912) Total long-term debt $ 166,631 35,000 $ 582 $ 202,213

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	6 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity	Information with respect to the Company’s non-vested time-based restricted stock units for the six months ended June 30, 2023 was as follows: Number of Restricted Stock Units Weighted- Weighted- Aggregate Shares Retained to Cover Statutory Minimum Withholding Taxes Non-vested at January 1, 2023 788,217 $28.24 — Granted 597,436 30.05 — Vested (332,078) 25.00 (109,740) Forfeited (42,805) 32.22 — Non-vested at June 30, 2023 1,010,770 $30.21 1.10 $32,314 Information with respect to the Company’s non-vested performance-based restricted stock units for the six months ended June 30, 2023 was as follows: Number of Performance-based Restricted Stock Units Weighted- Weighted- Aggregate Shares Retained to Cover Statutory Minimum Withholding Taxes Non-vested at January 1, 2023 294,011 $23.20 — Granted 240,598 26.12 — Vested (254,320) 15.34 (114,881) Forfeited — — — Non-vested at June 30, 2023 280,289 $32.85 1.43 $8,961
Share-based Payment Arrangement, Expensed and Capitalized, Amount	tock-based compensation expense by award type for the three and six months ended June 30, 2023 and 2022 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Share-based compensation expense by type: Time-based Restricted Stock Units $ 4,748 $ 2,952 $ 8,913 $ 5,380 Performance-based Restricted Stock Units 1,140 643 2,022 1,591 ESPP 54 50 100 96 Total share-based compensation expense $ 5,942 $ 3,645 $ 11,035 $ 7,067 Stock-based compensation was included in the following captions in the Company’s condensed consolidated statements of operations for the three and six months ended June 30, 2023 and 2022 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Cost of revenues $ 984 $ 589 $ 1,413 $ 1,015 Research and development expenses 1,216 515 1,684 865 Marketing and selling expenses 1,036 800 1,845 1,398 General and administrative expenses 2,706 1,741 6,093 3,789 Total share-based compensation expense $ 5,942 $ 3,645 $ 11,035 $ 7,067

NET INCOME PER SHARE Earnings_3

NET INCOME PER SHARE Earnings Per Share (Details) - shares shares in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Non-vested restricted stock units
Antidilutive Securities Excluded from Computation of Net Loss Per Share [Line Items]
Anti-dilutive potential common shares (in thousands of shares)	1,291	826

NET INCOME PER SHARE Weighted A

NET INCOME PER SHARE Weighted Average Shares Outstanding (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Earnings Per Share [Abstract]
Weighted-average common shares outstanding – basic	44,099	44,740	43,957	44,778
Net effect of common stock equivalents	0	370	0	502
Weighted-average common shares outstanding – diluted	44,099	45,110	43,957	45,280

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Financial Assets:
Deferred compensation assets	$ 281	$ 376
Quoted Prices in Active Markets for Identical Assets (Level 1)
Financial Assets:
Deferred compensation assets	87	85
Significant Other Observable Inputs (Level 2)
Financial Assets:
Deferred compensation assets	194	291
Significant Unobservable Inputs (Level 3)
Financial Assets:
Deferred compensation assets	$ 0	$ 0

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 6,964	$ 7,984
Work in process	288	288
Finished Goods	20,776	12,709
Total inventory	28,028	20,981
Finished goods, consigned	$ 2,400	$ 1,400

LEASES LEASES (Details)

LEASES LEASES (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Lessee, Lease, Description [Line Items]
Operating Lease, Weighted Average Discount Rate, Percent	6%		6%
Operating Lease, Weighted Average Remaining Lease Term	4 years 8 months 12 days		4 years 8 months 12 days
Finance Lease, Weighted Average Discount Rate, Percent	1.20%		1.20%
Operating Lease, Cost	$ 1.5	$ 1.4	$ 3	$ 2.9
Operating Lease, Payments	1.5	1.5	3.2	3.1
Short-term Lease, Cost	$ 0.5	$ 0.6	$ 1.1	$ 1.2
Minimum [Member]
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Term of Contract	1 year		1 year
Maximum [Member]
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Term of Contract	5 years		5 years

LEASES Maturity Schedule (Detai

LEASES Maturity Schedule (Details) $ in Thousands	Jun. 30, 2023 USD ($)
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2023 (excluding six months ended June 30, 2023)	$ 3,125
2024	5,840
2025	5,898
2026	5,958
2027	5,500
Thereafter	2,067
Total future minimum lease payments	28,388
Less effects of discounting	(3,822)
Total lease liabilities	(24,566)
Finance Lease, Liability, Payment, Due [Abstract]
2023 (excluding six months ended June 30, 2023)	94
2024	41
2025	0
2026	0
2027	0
Thereafter	0
Total future minimum lease payments	135
Less effects of discounting	0
Total lease liabilities	$ 135

LEASES Supplemental Balance She

LEASES Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Leases [Abstract]
Right of use assets	$ 20,756	$ 21,395
Accrued expenses and other current liabilities	(4,682)
Long-term lease liabilities	(19,884)	(20,470)
Total lease liabilities	(24,566)
Other assets	132
Accrued expenses and other current liabilities	135
Other long-term liabilities	0	$ (46)
Total lease liabilities	$ 135

OTHER LONG-TERM LIABILITIES (De

OTHER LONG-TERM LIABILITIES (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Other Liabilities Disclosure [Abstract]
Deferred compensation	$ 3,493	$ 3,715
Finance Lease, Liability, Noncurrent	0	46
Other long-term liabilities	551	587
Total	$ 4,044	$ 4,348

CONTINGENCIES (Details)

CONTINGENCIES (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022
Product warranty accrual [Roll Forward]
Accrual balance at beginning of year		$ 941	$ 1,219
Accruals for product warranties		354	305
Cost of warranty claims		(423)	(551)
Accrual balance at end of period	$ 872	872	$ 973
Standby Letters of Credit [Member] | Office Space - Burlington, Massachusetts [Member]
Loss Contingencies [Line Items]
Loss Contingency, Range of Possible Loss, Portion Not Accrued	700	700
Standby Letters of Credit [Member] | Office Space - Other Facilities [Member]
Loss Contingencies [Line Items]
Letters of Credit Outstanding, Amount	400	400
Standby Letters of Credit [Member] | Other Operating Obligations [Member]
Loss Contingencies [Line Items]
Letters of Credit Outstanding, Amount	3,400	3,400
Research and Development Arrangement [Member]
Loss Contingencies [Line Items]
Long-term Purchase Commitment, Amount	$ 32,200
Long-term Purchase Commitment, Period	5 years
Other Inventory, Purchased Goods, Gross	$ 23,500	$ 23,500

RESTRUCTURING COSTS AND ACCRUAL

RESTRUCTURING COSTS AND ACCRUALS (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) position	Jun. 30, 2022 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 5,462	$ 342	$ 5,462	$ 357
Restructuring and Related Cost, Number of Positions Eliminated | position			101
Employee Severance [Member]
Restructuring accrual [Roll Forward]
Accrual balance at beginning of year			$ 205
Cash payments			(1,029)
Foreign exchange impact on ending balance			5
Accrual balance at end of period	$ 4,653		4,653
New restructuring charges - operating expenses			$ 5,472

REVENUE Revenue by Type (Detail

REVENUE Revenue by Type (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)
Revenue from Contract with Customer [Abstract]
Number of reportable segments			1
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 108,542	$ 97,680	$ 206,353	$ 198,329

REVENUE Revenue by Geographic R

REVENUE Revenue by Geographic Regions (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 108,542	$ 97,680	$ 206,353	$ 198,329
United States
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	46,601	40,160	87,029	84,549
Other Americas
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	5,097	8,406	15,298	13,300
Europe, Middle East and Africa
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	41,006	36,316	73,927	75,161
Asia-Pacific
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 15,838	$ 12,798	$ 30,099	$ 25,319

REVENUE Contract Asset (Details

REVENUE Contract Asset (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Change in Contract with Customer, Asset [Abstract]
Contract asset at beginning of period	$ 37,765	$ 25,397
Revenue in excess of billings	47,651	19,735
Customer billings	(39,092)	(14,858)
Contract asset at end of period	46,324	$ 30,274
Less: long-term portion (recorded in other long-term assets)	7,837		$ 9,324
Contract asset, current portion	$ 38,487		$ 20,950

REVENUE Deferred Revenue Activi

REVENUE Deferred Revenue Activity (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Movement in Deferred Revenue [Roll Forward]
Deferred revenue at beginning of period	$ 94,150	$ 98,082
Billings deferred	40,831	45,192
Recognition of prior deferred revenue	(70,500)	(62,341)
Deferred revenue at end of period	64,481	80,933
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	14,700
Deferred Revenue	64,481	$ 80,933
Subscription
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	1,672
Subscription Arrangement [Member]
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	14,926
Maintenance contracts
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	42,885
Implied PCS
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	3,233
Professional services, training and other
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	$ 1,765

REVENUE Remaining Performance O

REVENUE Remaining Performance Obligations (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2027	Dec. 31, 2026	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Deferred Revenue Arrangement [Line Items]
Revenue, Performance Obligation, Description of Timing	six years
Remaining Performance Obligation	$ 14,700
Unbilled Receivables, Not Billable	13,400
Subscription
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	1,672
Subscription Arrangement [Member]
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	14,926
Maintenance contracts
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	42,885
Implied PCS
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	3,233
Implied PCS | Forecast [Member]
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation		$ 200	$ 400	$ 700	$ 1,100	$ 700
Professional services, training and other
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	$ 1,765

LONG-TERM DEBT AND CREDIT AGR_3

LONG-TERM DEBT AND CREDIT AGREEMENT - SCHEDULE OF LONG TERM DEBT (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
Debt Instrument [Line Items]
Term Loan, net of unamortized issuance costs and debt discount of $2,187 and $2,485 at June 30, 2023 and December 31, 2022, respectively	$ 177,375		$ 181,853
Other long-term debt			815
Total debt	213,125	$ 182,668
Less: current portion	10,912	9,710	$ 9,710
Total long-term debt	$ 202,213	$ 172,958

LONG-TERM DEBT AND CREDIT AGR_4

LONG-TERM DEBT AND CREDIT AGREEMENT Debt Disclosure (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
Debt Instrument, Periodic Payment, Principal	$ 4,858
Long-term Debt, Maturities, Repayments of Principal in Year Two	13,305
Long-term Debt, Maturities, Repayments of Principal in Year Three	18,093
Long-term Debt, Maturities, Repayments of Principal in Year Four	19,300
Long-term Debt, Maturities, Repayments of Principal in Year Five	159,756
Total debt	215,312
Convertible Notes unamortized issue discount and debt issuance costs	(2,187)
Less: current portion	(10,912)	$ (9,710)	$ (9,710)
Total long-term debt	202,213	$ 172,958
Revolving Credit Facility [Member]
Long-term Debt, Maturities, Repayments of Principal in Year Five	35,000
Total debt	179,562
Total long-term debt	166,631
Other Debt Obligations [Member]
Debt Instrument, Periodic Payment, Principal	83
Long-term Debt, Maturities, Repayments of Principal in Year Two	174
Long-term Debt, Maturities, Repayments of Principal in Year Three	187
Long-term Debt, Maturities, Repayments of Principal in Year Four	200
Long-term Debt, Maturities, Repayments of Principal in Year Five	106
Total debt	750
Convertible Notes unamortized issue discount and debt issuance costs	0
Less: current portion	(168)
Total long-term debt	$ 582

LONG-TERM DEBT AND CREDIT AGR_5

LONG-TERM DEBT AND CREDIT AGREEMENT Debt Disclosure1 (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Other long-term debt			$ 815
Total debt	$ 213,125	$ 213,125		$ 182,668
Less: current portion	10,912	10,912	9,710	$ 9,710
Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction		0	$ 440
Convertible Notes unamortized issue discount and debt issuance costs	(2,187)	(2,187)
Long-term Debt, Maturities, Repayments of Principal in Year Two	13,305	13,305
Long-term Debt, Maturities, Repayments of Principal in Year Three	18,093	18,093
Long-term Debt, Maturities, Repayments of Principal in Year Four	19,300	19,300
Long-term Debt, Maturities, Repayments of Principal in Year Five	159,756	159,756
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Minimum [Member] | Term Loan
Interest Expense, Long-term Debt	$ 3,800	$ 7,100
JPMorgan Chase | Revolving Credit Facility [Member]
Debt Instrument, Interest Rate, Effective Percentage	7.05%	7.05%

STOCKHOLDERS' EQUITY Non-vested

STOCKHOLDERS' EQUITY Non-vested Restricted Stock (Details) - Restricted Stock Units (RSUs) [Member] - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	1,010,770	788,217
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	597,436
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	(332,078)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	(42,805)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 30.21	$ 28.24
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	30.05
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	25
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	$ 32.22
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	1 year 1 month 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Non-vested Restricted Stock Aggregate Intrinsic Value	$ 32,314
Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation	(109,740)
Performance-Based Vesting [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	280,289	294,011
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	240,598
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	(254,320)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 32.85	$ 23.20
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	26.12
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	15.34
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	1 year 5 months 4 days
Share-based Compensation Arrangement by Share-based Payment Award, Non-vested Restricted Stock Aggregate Intrinsic Value	$ 8,961
Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation	(114,881)

STOCKHOLDERS' EQUITY Stock-base

STOCKHOLDERS' EQUITY Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-based Payment Arrangement, Expense	$ 5,942	$ 3,645	$ 11,035	$ 7,067
Restricted Stock Units (RSUs) [Member] | Time Based RSUs
Employee Benefits and Share-based Compensation	4,748	2,952	8,913	5,380
Restricted Stock Units (RSUs) [Member] | Performance-Based Vesting [Member]
Employee Benefits and Share-based Compensation	1,140	643	2,022	1,591
Employee Stock
Employee Benefits and Share-based Compensation	54	50	100	96
Cost of Products Revenues [Member]
Share-based Payment Arrangement, Expense	984	589	1,413	1,015
Research and Development Expense [Member]
Share-based Payment Arrangement, Expense	1,216	515	1,684	865
Selling and Marketing Expense [Member]
Share-based Payment Arrangement, Expense	1,036	800	1,845	1,398
General and Administrative Expense [Member]
Share-based Payment Arrangement, Expense	$ 2,706	$ 1,741	$ 6,093	$ 3,789

STOCKHOLDERS' EQUITY - Narrativ

STOCKHOLDERS' EQUITY - Narrative (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Sep. 09, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Repurchase Program, Authorized Amount					$ 115,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount				$ 36,600
Stock Repurchased During Period, Value	$ (420)	$ (14,143)	$ (10,816)
Treasury Stock, Common
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Repurchased During Period, Shares	(15)	(560)	(354)
Stock Repurchased During Period, Value	$ 420	$ 14,143	$ 10,816